FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by <sup>90</sup>yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases

FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by <sup>90</sup>yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases

<p>Abstract</p> <p>Background</p> <p>This retrospective analysis is focused on the efficacy and safety of radioimmunotherapy (RIT) with Zevalin<sup>® </sup>in nine patients with recurrent follicular lymphoma (FL) who were treated in a consolidation setting a...

Full description

Bibliographic Details
Main Authors: Assisi Daniela, D'Andrea Mariella, Dessanti Laura, Sciuto Rosa, Maini Carlo, Pisani Francesco, Petti Maria
Format: Article
Language:English
Published: BMC 2011-02-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/30/1/16

Similar Items

Similar Items